Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers
RNA-seq (gene expression) · human · 74 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 74 samples: 74 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE306117_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1309161 and SRA study SRP610522. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 40 samples read as cases, 23 as controls.
How we read this: Read from 74 sample titles: 74 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9193483 103-B27-Tumor
- GSM9193484 103-B36-Normal
- GSM9193485 106-3B-Tumor
- GSM9193486 106-3L-Normal
- GSM9193487 108-3N-Tumor
- GSM9193488 108-3T-Normal
- GSM9193489 120-3C-Tumor
- GSM9193490 120-3S-Normal
- GSM9193491 125-3I-Tumor
- GSM9193492 125-3O-Normal
- GSM9193493 126-B1-Normal
- GSM9193494 126-B4-Tumor
- GSM9193495 126-B7-Tumor
- GSM9193496 126-D2-contralateral
- GSM9193497 128-2O-surrounding_R
- GSM9193498 128-2C-Tumor
- GSM9193499 130-1L-Tumor
- GSM9193500 130-1O-Normal
- GSM9193501 152-2F-Tumor
- GSM9193502 152-NA-Normal
- GSM9193503 157-1M-Tumor
- GSM9193504 157-1V-Normal
- GSM9193505 160-3C-Tumor
- GSM9193506 160-3L-Normal
- GSM9193507 169-5H-Tumor
- GSM9193508 169-5I-Normal
- GSM9193509 177-3C-Tumor
- GSM9193510 177-3H-Tumor
- GSM9193511 177-3K-Normal
- GSM9193512 180-5C-Tumor
- GSM9193513 180-5J-Normal
- GSM9193514 186-6C-Normal
- GSM9193515 186-6Z-Tumor
- GSM9193516 187-1H-Normal
- GSM9193517 187-3C-Tumor
- GSM9193518 193-3F-Tumor
- GSM9193519 193-3H-Normal
- GSM9193520 196-2EE-Normal
- GSM9193521 196-2M-Tumor
- GSM9193522 197-2B-Tumor
+ 34 more — browse all 74 samples with per-sample file links →
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing · shares distinct
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE319130 Multi-omic analysis reveals molecular subtypes with distinct immunological phenotypes in SLE [RNA-Seq] 804 samples shares immunologic, distinct
- GSE300628 HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies 60 samples shares evolution, breast
- GSE316337 Multi-omics profiling reveals microbiota, metabolite, lipid, and immunological heterogeneity underlying distinct pathophysiological mechanisms of age-related endotypes in type 1 diabetes 54 samples shares immunologic, distinct
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.